Monograph Details
|
|
Musculoskeletal Disorders
> Muscle spasms
|
|
SOMA |
| Manufacturer |
|
Meda Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Muscle relaxant (central). |
| Generic Name |
|
Carisoprodol 350mg; tabs. |
| Also |
|
• SOMA 250
|
| Indications |
|
Relief of acute, painful musculoskeletal conditions. |
| Children |
|
<16yrs: not recommended. |
| Adults |
|
≥16yrs: 250mg–350mg 3 times daily and at bedtime. Max 2–3 weeks. |
| Contraindications |
|
Porphyria. |
| Precautions |
|
Renal or hepatic dysfunction. Drug abuse. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Sedative effects potentiated by alcohol, other CNS depressants. May be potentiated by CYP2C19 inhibitors (eg, omeprazole, fluvoxamine). May be antagonized by CYP2C19 inducers (eg, rifampin, St. John's Wort). |
| Adverse Reactions |
|
Dizziness, drowsiness, headache, GI upset, rash, tachycardia, orthostatic hypotension; rare idiosyncratic reactions (see literature). |
| How Supplied |
|
Tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
